scholarly journals Strategies to increase downloads of COVID–19 exposure notification apps: A discrete choice experiment

PLoS ONE ◽  
2021 ◽  
Vol 16 (11) ◽  
pp. e0258945
Author(s):  
Jemima A. Frimpong ◽  
Stéphane Helleringer
Keyword(s):  
Decision Making ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Financial Incentives ◽  
Choice Experiment ◽  
Real Life ◽  
Contact Tracing ◽  
Reference Scenario ◽  
Pragmatic Trials ◽  
The Us

Exposure notification apps have been developed to assist in notifying individuals of recent exposures to SARS-CoV-2. However, in several countries, such apps have had limited uptake. We assessed whether strategies to increase downloads of exposure notification apps should emphasize improving the accuracy of the apps in recording contacts and exposures, strengthening privacy protections and/or offering financial incentives to potential users. In a discrete choice experiment with potential app users in the US, financial incentives were more than twice as important in decision-making about app downloads, than privacy protections, and app accuracy. The probability that a potential user would download an exposure notification app increased by 40% when offered a $100 reward to download (relative to a reference scenario in which the app is free). Financial incentives might help exposure notification apps reach uptake levels that improve the effectiveness of contact tracing programs and ultimately enhance efforts to control SARS-CoV-2. Rapid, pragmatic trials of financial incentives for app downloads in real-life settings are warranted.

scholarly journals Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment

2020 ◽  
Vol 23 (7) ◽  
pp. 945-952
Author(s):  
Jorien Veldwijk ◽  
Jennifer Viberg Johansson ◽  
Bas Donkers ◽  
Esther W. de Bekker-Grob
Keyword(s):  
Decision Making ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Choice Experiment ◽  
Real Life ◽  
Life Decision

scholarly journals Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?

2016 ◽  
Vol 19 (2) ◽  
pp. 202-209 ◽  
Author(s):  
Jorien Veldwijk ◽  
Brigitte A.B. Essers ◽  
Mattijs S. Lambooij ◽  
Carmen D. Dirksen ◽  
Henriette A. Smit ◽  
...  
Keyword(s):  
Decision Making ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Choice Experiment ◽  
Decision Making Behavior

scholarly journals Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment

Haemophilia ◽  
2021 ◽  
Author(s):  
Michelle Witkop ◽  
George Morgan ◽  
Jamie O'Hara ◽  
Michael Recht ◽  
Tyler W. Buckner ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Patient Preferences ◽  
Choice Experiment ◽  
The Us

scholarly journals Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment

2017 ◽  
Vol 13 (1) ◽  
pp. 74-82 ◽  
Author(s):  
Aoife De Brún ◽  
Darren Flynn ◽  
Laura Ternent ◽  
Christopher I Price ◽  
Helen Rodgers ◽  
...  
Keyword(s):  
Decision Making ◽  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Choice Experiment ◽  
Onset Time ◽  
Stroke Onset ◽  
Related Factors ◽  
Intravenous Alteplase

Background Treatment with intravenous alteplase for eligible patients with acute ischemic stroke is underused, with variation in treatment rates across the UK. This study sought to elucidate factors influencing variation in clinicians’ decision-making about this thrombolytic treatment. Methods A discrete choice experiment using hypothetical patient vignettes framed around areas of clinical uncertainty was conducted with UK-based clinicians. Mixed logit regression analyses were conducted on the data. Results A total of 138 clinicians completed the discrete choice experiment. Seven patient factors were individually predictive of increased likelihood of immediately offering IV alteplase (compared to reference levels in brackets): stroke onset time 2 h 30 min [50 min]; pre-stroke dependency mRS 3 [mRS 4]; systolic blood pressure 185 mm/Hg [140 mm/Hg]; stroke severity scores of NIHSS 5 without aphasia, NIHSS 14 and NIHSS 23 [NIHSS 2 without aphasia]; age 85 [68]; Afro-Caribbean [white]. Factors predictive of withholding treatment with IV alteplase were: age 95 [68]; stroke onset time of 4 h 15 min [50 min]; severe dementia [no memory problems]; SBP 200 mm/Hg [140 mm/Hg]. Three clinician-related factors were predictive of an increased likelihood of offering IV alteplase (perceived robustness of the evidence for IV alteplase; thrombolyzing more patients in the past 12 months; and high discomfort with uncertainty) and one with a decreased likelihood (high clinician comfort with treating patients outside the licensing criteria). Conclusions Both patient- and clinician-related factors have a major influence on the use of alteplase to treat patients with acute ischemic stroke. Clinicians’ views of the evidence, comfort with uncertainty and treating patients outside the license criteria are important factors to address in programs that seek to reduce variation in care quality regarding treatment with IV alteplase. Further research is needed to further understand the differences in clinical decision-making about treating patients with acute ischemic stroke with IV alteplase.

scholarly journals Drivers of vaccine decision-making in South Africa: A discrete choice experiment

Vaccine ◽  
2019 ◽  
Vol 37 (15) ◽  
pp. 2079-2089 ◽  
Author(s):  
Frederik Verelst ◽  
Roselinde Kessels ◽  
Wim Delva ◽  
Philippe Beutels ◽  
Lander Willem
Keyword(s):  
South Africa ◽  
Decision Making ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Choice Experiment ◽  
Vaccine Decision Making
Sign in / Sign up

Export Citation Format

Share Document